Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 56117096600

Activities

Collapse all

Employment (3)

Ghent University: Ghent, BE

2024-08-15 to present | Post-doctoral researcher (GE32 - Diagnostic Sciences)
Employment
Source: Self-asserted source
Jeffrey Aalders

Ghent University: Ghent, BE

2024-01-15 to 2024-08-14 | Post-doctoral researcher (GE38 - Human Structure and Repair)
Employment
Source: Self-asserted source
Jeffrey Aalders

Ghent University: Ghent, BE

2017-01-15 to 2024-01-14 | PhD student/ Assisting Academic Staff (GE38 - Human Structure and Repair)
Employment
Source: Self-asserted source
Jeffrey Aalders

Works (15)

Exploring Aneuploidies in Two-Center Isolated Bovine Embryonic Stem Cell Lines: Implications for Cultured Meat Production

Future Foods
2025-01 | Journal article
DOI: 10.1016/j.fufo.2025.100555
Contributors: Chloë Deelkens; Elly De Vlieghere; Mario Van Poucke; Masaki Kinoshita; Jeffrey Aalders; Lieven Thorrez; Bert Devriendt; Ann Van Soom; Luc Peelman; Björn Menten et al.
Source: check_circle
Crossref

Generation of a human induced pluripotent stem cell line UGENTi002-A from an arrhythmogenic cardiomyopathy patient carrying the c.817C>T DSP heterozygous variant and isogenic control using CRISPR/Cas9 editing

Stem Cell Research
2024-12 | Journal article
DOI: 10.1016/j.scr.2024.103537
Part of ISSN: 1873-5061
Contributors: Laurens Léger; Jeffrey Aalders; Nina Heymans; Kiara Van Acker-Verberckt; Léa De Bleeckere; Paul Coucke; Björn Menten; Barbara Bauce; Libero Vitiello; Alessandra Rampazzo et al.
Source: Self-asserted source
Jeffrey Aalders

Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis

Regenerative Therapy
2024-12 | Journal article
DOI: 10.1016/j.reth.2024.02.007
Contributors: Jeffrey Aalders; Laurens Léger; Behrouz Hassannia; Vera Goossens; Tom Vanden Berghe; Jolanda van Hengel
Source: check_circle
Crossref

Photoporation-mediated spatial intracellular delivery of stem cell-derived cardiomyocytes

MethodsX
2024-06 | Journal article
DOI: 10.1016/j.mex.2024.102548
Part of ISSN: 2215-0161
Contributors: Laurens Léger; Chloë De Clercq; Jeffrey Aalders; Kiara Van Acker-Verberckt; Kevin Braeckmans; Jolanda van Hengel
Source: Self-asserted source
Jeffrey Aalders

Combinatorial effects of surface plasma-treating and aligning PCL/chitosan nanofibers on the behavior of stem cell-derived cardiomyocytes for cardiac tissue engineering

Applied Surface Science
2024-05 | Journal article
DOI: 10.1016/j.apsusc.2024.159680
Contributors: Laurens Léger; Sheida Aliakbarshirazi; Pegah Zahedifar; Jeffrey Aalders; Pascal Van Der Voort; Nathalie De Geyter; Rino Morent; Jolanda van Hengel; Rouba Ghobeira
Source: check_circle
Crossref

Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy

Matrix Biology
2024-02 | Journal article
DOI: 10.1016/j.matbio.2024.01.003
Contributors: Jeffrey Aalders; Laurens Léger; Louis Van der Meeren; Sanjay Sinha; Andre G. Skirtach; Julie De Backer; Jolanda van Hengel
Source: check_circle
Crossref

Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing

Stem Cell Research
2023-03 | Journal article
DOI: 10.1016/j.scr.2023.103036
Contributors: Jeffrey Aalders; Laurens Léger; Anthony Demolder; Laura Muiño Mosquera; Paul Coucke; Björn Menten; Julie De Backer; Jolanda van Hengel
Source: check_circle
Crossref

Photothermal nanofibres enable safe engineering of therapeutic cells

Nature Nanotechnology
2021-10-21 | Journal article
DOI: 10.1038/s41565-021-00976-3
Part of ISSN: 1748-3387
Part of ISSN: 1748-3395
Source: Self-asserted source
Jeffrey Aalders

Use of Transparent Liquid Marble: Microbioreactor to Culture Cardiospheres.

Methods in molecular biology (Clifton, N.J.)
2021-01-01 | Journal article
DOI: 10.1007/978-1-0716-1246-0_5
PMID: 33604846
Source: Self-asserted source
Jeffrey Aalders

Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling

MethodsX
2020 | Journal article
DOI: 10.1016/j.mex.2020.101065
Contributors: Jeffrey Aalders; Laurens Léger; Tim Tuerlings; Sergio Ledda; Jolanda van Hengel
Source: check_circle
Crossref

Effects of fibrillin mutations on the behavior of heart muscle cells in Marfan syndrome

Scientific Reports
2020-12 | Journal article
DOI: 10.1038/s41598-020-73802-w
Part of ISSN: 2045-2322
Source: Self-asserted source
Jeffrey Aalders

Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.

In vitro cellular & developmental biology. Animal
2019-10-29 | Journal article
DOI: 10.1007/s11626-019-00413-9
PMID: 31664691
Source: Self-asserted source
Jeffrey Aalders

Fungal bioreceptivity of Japanese tissue papers treated with plant dyes, watercolours, and acrylic paints in paper conservation

Studies in Conservation
2017 | Journal article
DOI: 10.1080/00393630.2015.1137132
EID:

2-s2.0-84978516930
Contributors: Soleymani, S.; Aalders, J.; Gahan, M.E.; Ireland, T.; McNevin, D.
Source: Self-asserted source
Jeffrey Aalders via Scopus - Elsevier

Assessing Teratogenicity from the Clustering of Abnormal Phenotypes in Individual Zebrafish Larvae.

Zebrafish
2016-08 | Journal article
DOI: 10.1089/zeb.2016.1284
PMID: 27560445
Contributors: Aalders J; Ali S; de Jong TJ; Richardson MK
Source: Self-asserted source
Jeffrey Aalders via Europe PubMed Central
grade
Preferred source (of 2)‎

Teratological effects of a panel of sixty water-soluble toxicants on zebrafish development.

Zebrafish
2014-03 | Journal article
DOI: 10.1089/zeb.2013.0901
PMID: 24650241
PMC: PMC3991996
Contributors: Ali S; Aalders J; Richardson MK
Source: Self-asserted source
Jeffrey Aalders via Europe PubMed Central
grade
Preferred source (of 2)‎

Peer review (11 reviews for 2 publications/grants)

Review activity for Communications medicine. (1)
Review activity for MethodsX. (10)
How many people are using ORCID?